This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2004 May-Jun;49(3):137-9.

doi: 10.1016/j.vascn.2004.03.011.

Safety pharmacology matures into a unique pharmacological discipline

Michael K Pugsley

PMID: 15172008
DOI: 10.1016/j.vascn.2004.03.011

Editorial

Safety pharmacology matures into a unique pharmacological discipline

Michael K Pugsley. J Pharmacol Toxicol Methods. 2004 May-Jun.

. 2004 May-Jun;49(3):137-9.

doi: 10.1016/j.vascn.2004.03.011.

Author

Michael K Pugsley

PMID: 15172008
DOI: 10.1016/j.vascn.2004.03.011

No abstract available

PubMed Disclaimer

Comment on

Origins, practices and future of safety pharmacology.
Bass A, Kinter L, Williams P. Bass A, et al. J Pharmacol Toxicol Methods. 2004 May-Jun;49(3):145-51. doi: 10.1016/j.vascn.2004.02.007. J Pharmacol Toxicol Methods. 2004. PMID: 15172010 Review.

Similar articles

Origins, practices and future of safety pharmacology.
Bass A, Kinter L, Williams P. Bass A, et al. J Pharmacol Toxicol Methods. 2004 May-Jun;49(3):145-51. doi: 10.1016/j.vascn.2004.02.007. J Pharmacol Toxicol Methods. 2004. PMID: 15172010 Review.
Safety pharmacology and risk assessment.
Kinter LB, Valentin JP. Kinter LB, et al. Fundam Clin Pharmacol. 2002 Jun;16(3):175-82. doi: 10.1046/j.1472-8206.2002.00104.x. Fundam Clin Pharmacol. 2002. PMID: 12165065 Review.
Introduction to nonclinical safety pharmacology and the safety pharmacology society.
Bass AS, Vargas HM, Kinter LB. Bass AS, et al. J Pharmacol Toxicol Methods. 2004 May-Jun;49(3):141-4. doi: 10.1016/j.vascn.2004.02.004. J Pharmacol Toxicol Methods. 2004. PMID: 15172009 No abstract available.
Safety pharmacology--a progressive approach.
Redfern WS, Wakefield ID, Prior H, Pollard CE, Hammond TG, Valentin JP. Redfern WS, et al. Fundam Clin Pharmacol. 2002 Jun;16(3):161-73. doi: 10.1046/j.1472-8206.2002.00098.x. Fundam Clin Pharmacol. 2002. PMID: 12165064
[Research in the field of clinical pharmacology in the USSR].
Lakin KM, Makarov VA, Novikova NV. Lakin KM, et al. Farmakol Toksikol. 1982 May-Jun;45(3):5-12. Farmakol Toksikol. 1982. PMID: 7047211 Clinical Trial. Russian.

See all similar articles

Cited by

Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies.
Andrade EL, Bento AF, Cavalli J, Oliveira SK, Schwanke RC, Siqueira JM, Freitas CS, Marcon R, Calixto JB. Andrade EL, et al. Braz J Med Biol Res. 2016 Dec 12;49(12):e5646. doi: 10.1590/1414-431X20165646. Braz J Med Biol Res. 2016. PMID: 27982281 Free PMC article. Review.
Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation.
Clements-Jewery H, Hearse DJ, Curtis MJ. Clements-Jewery H, et al. Br J Pharmacol. 2005 Jul;145(5):551-64. doi: 10.1038/sj.bjp.0706231. Br J Pharmacol. 2005. PMID: 15852034 Free PMC article. Review.
Principles of safety pharmacology.
Pugsley MK, Authier S, Curtis MJ. Pugsley MK, et al. Br J Pharmacol. 2008 Aug;154(7):1382-99. doi: 10.1038/bjp.2008.280. Epub 2008 Jul 7. Br J Pharmacol. 2008. PMID: 18604233 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science